JP2019532668A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532668A5 JP2019532668A5 JP2019531525A JP2019531525A JP2019532668A5 JP 2019532668 A5 JP2019532668 A5 JP 2019532668A5 JP 2019531525 A JP2019531525 A JP 2019531525A JP 2019531525 A JP2019531525 A JP 2019531525A JP 2019532668 A5 JP2019532668 A5 JP 2019532668A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chimeric receptor
- human
- receptor ligand
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610795955.X | 2016-08-31 | ||
| CN201610795955.XA CN107793481A (zh) | 2016-08-31 | 2016-08-31 | 一种靶向人cd123的嵌合受体配体及其应用 |
| PCT/CN2017/099941 WO2018041220A1 (zh) | 2016-08-31 | 2017-08-31 | 一种靶向人cd123的嵌合受体配体及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532668A JP2019532668A (ja) | 2019-11-14 |
| JP2019532668A5 true JP2019532668A5 (enExample) | 2020-10-08 |
| JP6990244B2 JP6990244B2 (ja) | 2022-01-12 |
Family
ID=61300124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531525A Expired - Fee Related JP6990244B2 (ja) | 2016-08-31 | 2017-08-31 | ヒトｃｄ１２３を標的とするキメラ受容体リガンド及びその応用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11401317B2 (enExample) |
| EP (1) | EP3508504A4 (enExample) |
| JP (1) | JP6990244B2 (enExample) |
| CN (1) | CN107793481A (enExample) |
| WO (1) | WO2018041220A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110157678A (zh) * | 2018-02-12 | 2019-08-23 | 深圳宾德生物技术有限公司 | 一种靶向性t淋巴细胞及其制备方法和应用 |
| JP7447388B2 (ja) * | 2018-07-13 | 2024-03-12 | ナンジン レジェンド バイオテック カンパニー，リミテッド | 感染性疾患の治療のための共受容体システム |
| CN109970869A (zh) * | 2019-04-12 | 2019-07-05 | 南京卡提医学科技有限公司 | 一种靶向人trail死亡受体的嵌合受体配体及其应用 |
| CN110904048A (zh) * | 2019-12-04 | 2020-03-24 | 合肥中科干细胞再生医学有限公司 | 一种car-cd123t2嵌合抗原受体t细胞及其应用 |
| WO2023000036A1 (en) * | 2021-07-22 | 2023-01-26 | The Westmead Institute for Medical Research | Chimeric antigen receptor useful in treating cancer |
| US20250082755A1 (en) * | 2021-07-29 | 2025-03-13 | Vor Biopharma Inc. | Chimeric antigen receptors for treatment of cancer |
| CN117126856A (zh) * | 2022-05-20 | 2023-11-28 | 上海雅科生物科技有限公司 | 以bcma胞外结构域为标记的基因、多肽、重组表达载体、基因工程化细胞及其应用 |
| CN115819622A (zh) * | 2022-09-26 | 2023-03-21 | 湖南省人民医院(湖南师范大学附属第一医院) | 针对b系白血病或淋巴瘤的双靶点car结构及药物组合物 |
| CN116179495B (zh) * | 2022-11-28 | 2025-06-06 | 上海恩凯细胞技术有限公司 | 转基因免疫细胞及其应用 |
| CN117659196B (zh) * | 2023-12-12 | 2024-08-23 | 成都优赛诺生物科技有限公司 | 一种靶向cd7的单域抗体、嵌合抗原受体及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3207941T (pt) * | 2006-09-07 | 2020-04-02 | Scott & White Memorial Hospital | Métodos e composições baseados em conjugados de toxina diftérica-interleucina-3 |
| PL3006459T3 (pl) * | 2008-08-26 | 2022-01-17 | City Of Hope | Sposób i kompozycje dla wzmocnionego działania efektorowego komórek t przeciw guzowi nowotworowemu |
| AU2013312838B2 (en) * | 2012-09-04 | 2018-11-29 | Cellectis | Multi-chain chimeric antigen receptor and uses thereof |
| US9657105B2 (en) * | 2013-03-15 | 2017-05-23 | City Of Hope | CD123-specific chimeric antigen receptor redirected T cells and methods of their use |
| ES2740903T3 (es) * | 2014-03-19 | 2020-02-07 | Cellectis | Receptores antigénicos quiméricos específicos de CD123 para inmunoterapia del cáncer |
| EP3158064A1 (en) * | 2014-06-17 | 2017-04-26 | Cellectis | Cd123 specific multi-chain chimeric antigen receptor |
| MY189028A (en) * | 2014-08-19 | 2022-01-20 | Novartis Ag | Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment |
-
2016
- 2016-08-31 CN CN201610795955.XA patent/CN107793481A/zh active Pending
-
2017
- 2017-08-31 EP EP17845522.6A patent/EP3508504A4/en not_active Withdrawn
- 2017-08-31 US US16/329,739 patent/US11401317B2/en active Active
- 2017-08-31 JP JP2019531525A patent/JP6990244B2/ja not_active Expired - Fee Related
- 2017-08-31 WO PCT/CN2017/099941 patent/WO2018041220A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019532668A5 (enExample) | ||
| HRP20231542T1 (hr) | Kimerni antigenski receptori koji ciljaju bcma i postupci njihove uporabe | |
| JP2019527557A5 (enExample) | ||
| JP2021087455A5 (enExample) | ||
| JP2021094037A5 (enExample) | ||
| JP2020517295A5 (enExample) | ||
| JP2017529851A5 (enExample) | ||
| JP2023059873A5 (enExample) | ||
| JP2021106605A5 (enExample) | ||
| JP2017533706A5 (enExample) | ||
| JP2020114264A5 (enExample) | ||
| JP2016514691A5 (enExample) | ||
| JP2016534717A5 (enExample) | ||
| FI3909972T3 (fi) | Pd1-cd28-fuusioproteiineja ja niiden käyttö lääkkeessä | |
| JP2018516092A5 (enExample) | ||
| JP2020512005A5 (enExample) | ||
| JP2017519502A5 (enExample) | ||
| JP2018525033A5 (enExample) | ||
| JP2018521663A5 (enExample) | ||
| JP2020513829A5 (enExample) | ||
| JP2017518071A5 (enExample) | ||
| HRP20211978T1 (hr) | Kimerični antigenski receptori koji ciljaju receptor spojen na g-protein i njihove uporabe | |
| FI3710067T3 (fi) | Polypeptidejä sisältävä d-domeeni ja niiden käyttötarkoitukset | |
| JP2019500894A5 (enExample) | ||
| RU2015109631A (ru) | Способ и композиции для клеточной иммунотерапии |